Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | NRIX |
---|---|---|
09:32 ET | 2874 | 21.8 |
09:34 ET | 160 | 21.805 |
09:36 ET | 300 | 21.845 |
09:38 ET | 300 | 21.74 |
09:39 ET | 100 | 22.075 |
09:41 ET | 3732 | 22.18 |
09:43 ET | 16960 | 22.18 |
09:45 ET | 100 | 22.02 |
09:48 ET | 9900 | 22.105 |
09:50 ET | 600 | 22.06 |
09:52 ET | 1500 | 21.97 |
09:54 ET | 293 | 21.97 |
09:56 ET | 611 | 21.98 |
09:57 ET | 707 | 21.95 |
09:59 ET | 900 | 22.025 |
10:01 ET | 2834 | 22.11 |
10:03 ET | 2772 | 22.06 |
10:08 ET | 813 | 21.95 |
10:10 ET | 2474 | 22.16 |
10:12 ET | 300 | 22.09 |
10:14 ET | 400 | 22.1 |
10:15 ET | 2207 | 21.995 |
10:17 ET | 500 | 21.96 |
10:19 ET | 15330 | 21.94 |
10:21 ET | 600 | 21.905 |
10:24 ET | 600 | 21.74 |
10:26 ET | 376 | 21.765 |
10:28 ET | 559 | 21.78 |
10:30 ET | 1279 | 21.74 |
10:32 ET | 400 | 21.76 |
10:33 ET | 1799 | 21.69 |
10:35 ET | 1048 | 21.65 |
10:37 ET | 100 | 21.67 |
10:39 ET | 700 | 21.65 |
10:42 ET | 1000 | 21.575 |
10:44 ET | 1000 | 21.41 |
10:48 ET | 1315 | 21.48 |
10:50 ET | 200 | 21.54 |
10:51 ET | 300 | 21.5 |
10:53 ET | 1300 | 21.43 |
10:55 ET | 100 | 21.48 |
10:57 ET | 1881 | 21.71 |
11:00 ET | 1306 | 21.65 |
11:02 ET | 511 | 21.61 |
11:04 ET | 5368 | 21.675 |
11:06 ET | 200 | 21.65 |
11:08 ET | 700 | 21.68 |
11:09 ET | 100 | 21.68 |
11:11 ET | 926 | 21.69 |
11:13 ET | 3300 | 21.55 |
11:15 ET | 100 | 21.555 |
11:18 ET | 800 | 21.64 |
11:20 ET | 700 | 21.61 |
11:22 ET | 200 | 21.52 |
11:24 ET | 351 | 21.54 |
11:27 ET | 300 | 21.64 |
11:29 ET | 1833 | 21.61 |
11:31 ET | 360 | 21.63 |
11:33 ET | 600 | 21.66 |
11:36 ET | 656 | 21.63 |
11:38 ET | 800 | 21.585 |
11:42 ET | 300 | 21.56 |
11:44 ET | 200 | 21.57 |
11:45 ET | 200 | 21.58 |
11:47 ET | 500 | 21.61 |
11:49 ET | 538 | 21.63 |
11:51 ET | 546 | 21.71 |
11:54 ET | 1702 | 21.65 |
11:58 ET | 497 | 21.64 |
12:00 ET | 100 | 21.63 |
12:02 ET | 300 | 21.62 |
12:03 ET | 600 | 21.59 |
12:05 ET | 400 | 21.56 |
12:09 ET | 600 | 21.565 |
12:12 ET | 660 | 21.605 |
12:14 ET | 800 | 21.525 |
12:18 ET | 1249 | 21.56 |
12:20 ET | 100 | 21.575 |
12:23 ET | 477 | 21.595 |
12:25 ET | 7958 | 21.805 |
12:27 ET | 500 | 21.79 |
12:30 ET | 500 | 21.85 |
12:32 ET | 1300 | 21.765 |
12:34 ET | 463 | 21.765 |
12:38 ET | 4483 | 21.69 |
12:39 ET | 1100 | 21.695 |
12:41 ET | 200 | 21.67 |
12:43 ET | 1501 | 21.62 |
12:45 ET | 977 | 21.68 |
12:48 ET | 220 | 21.68 |
12:50 ET | 1142 | 21.62 |
12:54 ET | 474 | 21.6 |
12:56 ET | 100 | 21.59 |
12:57 ET | 834 | 21.63 |
12:59 ET | 1200 | 21.53 |
01:03 ET | 1038 | 21.49 |
01:06 ET | 1984 | 21.475 |
01:08 ET | 400 | 21.47 |
01:10 ET | 530 | 21.5 |
01:12 ET | 1169 | 21.425 |
01:14 ET | 635 | 21.46 |
01:15 ET | 500 | 21.45 |
01:17 ET | 727 | 21.44 |
01:19 ET | 200 | 21.42 |
01:21 ET | 312 | 21.45 |
01:24 ET | 200 | 21.5 |
01:26 ET | 750 | 21.45 |
01:28 ET | 400 | 21.43 |
01:30 ET | 1619 | 21.29 |
01:32 ET | 1200 | 21.32 |
01:33 ET | 785 | 21.34 |
01:35 ET | 100 | 21.35 |
01:37 ET | 420 | 21.34 |
01:39 ET | 700 | 21.3 |
01:42 ET | 830 | 21.24 |
01:44 ET | 200 | 21.26 |
01:46 ET | 500 | 21.24 |
01:48 ET | 500 | 21.32 |
01:50 ET | 300 | 21.3 |
01:51 ET | 559 | 21.29 |
01:53 ET | 419 | 21.29 |
01:55 ET | 100 | 21.29 |
01:57 ET | 16528 | 21.34 |
02:00 ET | 4400 | 21.44 |
02:02 ET | 1186 | 21.45 |
02:04 ET | 300 | 21.41 |
02:06 ET | 100 | 21.4 |
02:08 ET | 100 | 21.43 |
02:09 ET | 200 | 21.5 |
02:11 ET | 300 | 21.5 |
02:13 ET | 500 | 21.53 |
02:15 ET | 200 | 21.535 |
02:18 ET | 900 | 21.585 |
02:20 ET | 300 | 21.62 |
02:22 ET | 1100 | 21.565 |
02:24 ET | 8432 | 21.59 |
02:26 ET | 1151 | 21.58 |
02:27 ET | 1373 | 21.59 |
02:29 ET | 1010 | 21.555 |
02:31 ET | 912 | 21.55 |
02:33 ET | 6110 | 21.465 |
02:36 ET | 1400 | 21.4275 |
02:38 ET | 1074 | 21.43 |
02:40 ET | 1099 | 21.37 |
02:42 ET | 200 | 21.42 |
02:44 ET | 267 | 21.4466 |
02:45 ET | 1376 | 21.44 |
02:47 ET | 1050 | 21.375 |
02:49 ET | 1978 | 21.405 |
02:51 ET | 986 | 21.45 |
02:54 ET | 200 | 21.42 |
02:56 ET | 17360 | 21.45 |
02:58 ET | 1992 | 21.44 |
03:00 ET | 2149 | 21.32 |
03:02 ET | 1088 | 21.32 |
03:03 ET | 400 | 21.35 |
03:05 ET | 2300 | 21.37 |
03:07 ET | 2405 | 21.43 |
03:09 ET | 2250 | 21.445 |
03:12 ET | 1547 | 21.445 |
03:14 ET | 3442 | 21.45 |
03:16 ET | 700 | 21.445 |
03:18 ET | 517 | 21.44 |
03:20 ET | 697 | 21.49 |
03:21 ET | 1017 | 21.45 |
03:23 ET | 262 | 21.465 |
03:25 ET | 4707 | 21.42 |
03:27 ET | 1383 | 21.46 |
03:30 ET | 100 | 21.49 |
03:32 ET | 726 | 21.515 |
03:34 ET | 67998 | 21.635 |
03:38 ET | 100 | 21.71 |
03:39 ET | 300 | 21.71 |
03:41 ET | 900 | 21.69 |
03:43 ET | 846 | 21.61 |
03:45 ET | 1756 | 21.61 |
03:48 ET | 900 | 21.58 |
03:50 ET | 1800 | 21.65 |
03:52 ET | 2233 | 21.64 |
03:54 ET | 2445 | 21.555 |
03:56 ET | 3822 | 21.66 |
03:57 ET | 4288 | 21.64 |
03:59 ET | 75749 | 21.67 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Nurix Therapeutics Inc | 1.4B | -7.4x | --- |
Arcus Biosciences Inc | 1.4B | -4.9x | --- |
Immatics NV | 1.1B | -11.3x | --- |
Arvinas Inc | 1.7B | -4.6x | --- |
Arcutis Biotherapeutics Inc | 1.2B | -4.7x | --- |
WAVE Life Sciences Ltd | 1.2B | -14.7x | --- |
Nurix Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the discovery, development and commercialization of small molecules and antibody therapies based on the modulation of cellular protein levels as a treatment approach for cancer, inflammatory conditions and other diseases. It DELigase is an integrated discovery platform, to identify and advance drug candidates targeting E3 ligases. Its drug candidates include NX-2127, NX-5948 and NX-1607. NX-2127 is an orally bioavailable Brutons tyrosine kinase (BTK) degrader that also degrades cereblon neosubstrates IKZF1 (Ikaros) and IKZF3 (Aiolos) for the treatment of relapsed or refractory B-cell malignancies. NX-5948 is an orally bioavailable BTK degrader for the treatment of relapsed or refractory B-cell malignancies and potentially autoimmune diseases. NX-1607 is an oral clinical-stage small molecule drug candidate that inhibits Casitas B-lineage lymphoma proto-oncogene-B (CBL-B).
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $1.4B |
---|---|
Revenue (TTM) | $62.3M |
Shares Outstanding | 64.4M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 2.23 |
EPS | $-2.92 |
Book Value | $4.12 |
P/E Ratio | -7.4x |
Price/Sales (TTM) | 22.4 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -287.47% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.